TC Biopharm (Holdings) PLC TCBPY
$0.01
Last Updated: Apr 09, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
T
TC Biopharm (Holdings) PLC. Stock Analysis TCBPY
United States Health Care Nano Cap TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company employs 39 full-time employees The company went IPO on 2022-02-23. The firm is conducting two investigator-initiated clinical trials for its unmodified GD-T cell product line - phase IIb/III pivotal trial in treatment of AML using its allogeneic CryoTC technology to provide frozen product to clinics worldwide. Its lead product candidate, OmnImmune is an unmodified allogeneic GD-T cell product, being initially used for the treatment of AML. Its pre-clinical stage program is focused on developing CAR-modified allogeneic GD-T cell products targeting solid and hematological indications. The company has an Israeli patent and Japanese patent applications covering the method of preparing and using GD-T cells in the allogeneic treatment of subjects suffering from viral, fungal and protozoal infections or cancer.
TC Biopharm (Holdings) PLC (TCBPY) Chart
Financial Metrics & Statements of TC Biopharm (Holdings) PLC (TCBPY)
FAQ's for TC Biopharm (Holdings) PLC (TCBPY)
- As of August 2026, TC Biopharm (Holdings) PLC TCBPY is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes TC Biopharm (Holdings) PLC using these criteria to determine its compliance status.
- Muslim investors may consider investing in TC Biopharm (Holdings) PLC if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of TC Biopharm (Holdings) PLC by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of TC Biopharm (Holdings) PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of TC Biopharm (Holdings) PLC on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for TC Biopharm (Holdings) PLC (TCBPY)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
